ID   Ubigene SU-DHL-4 SGK1 KO
AC   CVCL_E1CE
SY   SGK1 Knockout cell line (SU-DHL-4)
DR   Ubigene; YKO-H188
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 10810; SGK1.
CC   Sequence variation: Gene fusion; HGNC; 990; BCL2 + HGNC; 5477; IGH; Name(s)=IGH-BCL2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 3527; EZH2; Simple; p.Tyr646Ser (c.1937A>C) (Y641S); ClinVar=VCV000376218; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 3527; EZH2; Simple; p.Tyr666Asn (c.1996T>A) (Y661N); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0539 ! SU-DHL-4
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//